Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Proteome Science|April 6, 2006
A systems approach to clinical oncology: focus on breast cancerMark Abramovitz, Brian Leyland-JonesCancer Genomics & Proteomics|September 20, 2007
Application of array-based genomic and epigenomic technologies to unraveling the heterogeneous nature of breast tumors: on the road to individualized treatmentMark Abramovitz, Brian Leyland-JonesEuropean Journal of Cancer (Oxford, England : 1990)|November 4, 2008
Proteomics: new technologies and clinical applicationsMartin Latterich, Mark Abramovitz, Brian Leyland-JonesClinical Breast Cancer|July 21, 2016
Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast CancerMark Abramovitz, Casey Williams, Sibylle Loibl, et al.Current Opinion in Oncology|September 9, 2016
Identifying biomarkers to select patients with early breast cancer suitable for extended adjuvant endocrine therapyMark Abramovitz, Amy Krie, Nandini Dey, et al.Molecular and Biochemical Parasitology|January 5, 2002
A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamineFadi F Hamdan, Mark Abramovitz, Aisha Mousa, et al.Molecular Pharmacology|November 17, 2010
Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assaysDong Yan, Rino Stocco, Nicole Sawyer, et al.Plos One|October 22, 2013
Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent mannerNandini Dey, Brandon Young, Mark Abramovitz, et al.Plos One|February 18, 2016
Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-AnalysisScooter Willis, Victor M Villalobos, Olivier Gevaert, et al.Cancer Chemotherapy and Pharmacology|September 22, 2019
Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancerYuliang Sun, Xiaoqian Lin, Jennifer Carlson Aske, et al.Pageof 3